Related references
Note: Only part of the references are listed.Toward the Design of Ligands Selective for the C-Terminal Domain of TEADs
Maxime Liberelle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer
Shenghong Ma et al.
NATURE COMMUNICATIONS (2022)
Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors
Manon Sturbaut et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Association of subcellular localization of TEAD transcription factors with outcome and progression in pancreatic ductal adenocarcinoma
Richard Drexler et al.
PANCREATOLOGY (2021)
Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma
Tracy T. Tang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity
Joel D. Pearson et al.
CANCER CELL (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
The emerging role of Hippo signaling in neurodegeneration
Manas Ranjan Sahu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2020)
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway
Kari J. Kurppa et al.
CANCER CELL (2020)
TEAD1 and TEAD3 Play Redundant Roles in the Regulation of Human Epidermal Proliferation
Jingting Li et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Lats1/2 Sustain Intestinal Stem Cells and Wnt Activation through TEAD-Dependent and Independent Transcription
Qi Li et al.
CELL STEM CELL (2020)
The Effects of YAP and Its Related Mechanisms in Central Nervous System Diseases
Jiayan Jin et al.
FRONTIERS IN NEUROSCIENCE (2020)
Multiple Roles of Vestigial-Like Family Members in Tumor Development
Noritaka Yamaguchi
FRONTIERS IN ONCOLOGY (2020)
Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Anwesha Dey et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling
Jeffrey K. Holden et al.
CELL REPORTS (2020)
Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket
Hacer Karatas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A protein tertiary structure mimetic modulator of the Hippo signalling pathway
Helene Adihou et al.
NATURE COMMUNICATIONS (2020)
Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy
Fedir Bokhovchuk et al.
FEBS JOURNAL (2019)
Structure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence
Pascal Furet et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Vestigial like family member 3 is a novel prognostic biomarker for gastric cancer
Li-Hua Zhang et al.
WORLD JOURNAL OF CLINICAL CASES (2019)
Identification of Quinolinols as Activators of TEAD-Dependent Transcription
Ajaybabu V. Pobbati et al.
ACS CHEMICAL BIOLOGY (2019)
Fluorescence polarization assay for the identification and evaluation of inhibitors at YAP-TEAD protein-protein interface 3
Wei Zhou et al.
ANALYTICAL BIOCHEMISTRY (2019)
Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors
Wenchao Lu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine
Ivan M. Moya et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma
Jie Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD•Yap Protein-Protein Interaction
Khuchtumur Bum-Erdene et al.
CELL CHEMICAL BIOLOGY (2019)
Targeting Transcriptional Enhanced Associate Domains (TEADs)
Floriane Gibault et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
Shumei Song et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
Yoshitaka Sekido
CANCERS (2018)
Interplay between YAP/TAZ and Metabolism
Ja Hyun Koo et al.
CELL METABOLISM (2018)
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
Sebastian Mueller et al.
NATURE (2018)
Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review
James J. Crawford et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Hippo pathway mediates resistance to cytotoxic drugs
Taranjit S. Gujral et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner
Y. Liu et al.
ONCOGENE (2016)
Neurofibromatosis 2 (NF2) controls the invasiveness of glioblastoma through YAP-dependent expression of CYR61/CCN1 and miR-296-3p
Hong Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway
PuiYee Chan et al.
NATURE CHEMICAL BIOLOGY (2016)
Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling
Cameron L. Noland et al.
STRUCTURE (2016)
Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse
Matthieu Corvaisier et al.
ONCOTARGET (2016)
Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy
Ajaybabu V. Pobbati et al.
STRUCTURE (2015)
TAZ promotes epithelial to mesenchymal transition via the upregulation of connective tissue growth factor expression in neuroblastoma cells
Qiang Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi et al.
NATURE REVIEWS CANCER (2015)
YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway
Yulei Zhao et al.
CANCER RESEARCH (2014)
Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition
Maren Diepenbruck et al.
JOURNAL OF CELL SCIENCE (2014)
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Randy Johnson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival
Moritz Menzel et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
The TEAD4-YAP/TAZ Protein-Protein Interaction: Expected Similarities and Unexpected Differences
Jean Christophe Hau et al.
CHEMBIOCHEM (2013)
TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
Makiko Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Alteration of TEAD1 Expression Levels Confers Apoptotic Resistance through the Transcriptional Up-Regulation of Livin
Andre Landin Malt et al.
PLOS ONE (2012)
Structural insights into the YAP and TEAD complex
Ze Li et al.
GENES & DEVELOPMENT (2010)
TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
J. F. Knight et al.
BRITISH JOURNAL OF CANCER (2008)
YAP1 increases organ size and expands undifferentiated progenitor cells
Fernando D. Camargo et al.
CURRENT BIOLOGY (2007)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Share Paper
